Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Partin

Showing results (191-200 of 234) with videos related to

Pageof 24
Sort By:
Urology|February 1, 1995
Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volumeA W Partin, S R Criley, M S Steiner, et al.
Medical and Pediatric Oncology|January 1, 1993
The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a reviewA W Partin, J P Gearhart, M P Leonard, et al.
Urology|March 1, 1997
Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisH B Carter, A W Partin, A A Luderer, et al.
Urology|December 31, 1997
Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteinsA W Partin, J V Briggman, E N Subong, et al.
Electrophoresis|December 28, 1999
Exploratory data analysis groupware for qualitative and quantitative electrophoretic gel analysis over the Internet-WebGelP F Lemkin, J M Myrick, Y Lakshmanan, et al.
Hybridoma|January 8, 2000
Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassayT J Wang, H J Linton, J Payne, et al.
JAMA|May 14, 1997
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updateA W Partin, M W Kattan, E N Subong, et al.
The Journal of Urology|April 1, 1990
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasiaA W Partin, H B Carter, D W Chan, et al.
The Prostate|July 21, 2004
Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOFM B Gretzer, D W Chan, C L van Rootselaar, et al.
Urology|May 1, 1994
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesA W Partin, J D Pearson, P K Landis, et al.
Pageof 24

Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
Urology|February 1, 1995
Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volumeA W Partin, S R Criley, M S Steiner, et al.
Medical and Pediatric Oncology|January 1, 1993
The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a reviewA W Partin, J P Gearhart, M P Leonard, et al.
Urology|March 1, 1997
Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisH B Carter, A W Partin, A A Luderer, et al.
Urology|December 31, 1997
Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteinsA W Partin, J V Briggman, E N Subong, et al.
Electrophoresis|December 28, 1999
Exploratory data analysis groupware for qualitative and quantitative electrophoretic gel analysis over the Internet-WebGelP F Lemkin, J M Myrick, Y Lakshmanan, et al.
Hybridoma|January 8, 2000
Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassayT J Wang, H J Linton, J Payne, et al.
JAMA|May 14, 1997
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updateA W Partin, M W Kattan, E N Subong, et al.
The Journal of Urology|April 1, 1990
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasiaA W Partin, H B Carter, D W Chan, et al.
The Prostate|July 21, 2004
Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOFM B Gretzer, D W Chan, C L van Rootselaar, et al.
Urology|May 1, 1994
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesA W Partin, J D Pearson, P K Landis, et al.
Pageof 24